Oct 21, 2016 at 11:56 | Source: CNBC-TV18
Biotechnology major Biocon reported 19.8 percent rise in revenue to Rs 796.2 crore year-on-year and margins grew to 25.2 percent from 21.2 percent in the second quarter of FY17. The companys standalones sale grew 17 percent in Q2.
Oct 18, 2016 at 12:30 | Source: PTI
"USFDA (US Food & Drug Administration) has granted approval for an abbreviated new drug application (ANDA) for Paricalcitol Capsules 1 mcg, 2 mcg and 4 mcg," Marksans Pharma said in a BSE filing today.
Oct 13, 2016 at 15:52 | Source: PTI
The drug, a therapeutic equivalent generic version of Abilify (Aripiprazole) tablets, has been introduced in the world's biggest pharma market after getting approval from the US Food and Drug Administration (USFDA), the city-based company said in a statement.
Oct 12, 2016 at 19:20 | Source: PTI
Drug major Cipla today said it has received Establishment Inspection Report from the US health regulator for its Indore plant after completion of the inspection there.
Oct 12, 2016 at 14:26 | Source: PTI
The recall has been initiated by Sun Pharmaceutical Industries Inc for 31,762 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strength of 150 mg, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.
Oct 05, 2016 at 11:46 | Source: PTI
"The company's formulation facility located at Panelav has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (FDA) for the inspection carried out by them in March 2016," Alembic Pharmaceuticals said in a BSE filing.
Oct 04, 2016 at 12:56 | Source: PTI
"The company has received an approval from the United States Food & Drug Administration (USFDA) for Azacitidine- Injection ANDA of SEZ formulations facility situated at Jadcherla, near Hyderabad," Shilpa Medicare said in a BSE filing.
Oct 04, 2016 at 12:04 | Source: Moneycontrol.com
Aurobindo Pharma gained 1.4 percent and Shilpa Medicare rallied 3.4 percent intraday Tuesday after getting approval from the US health regulator for HIV and chemotherapy drugs, respectively.
Sep 30, 2016 at 14:20 | Source: PTI
"United States Food and Drug Administration (USFDA) recently concluded audit of our three manufacturing facilities in Goa and has issued four observations across these three facilities," Cipla said in a filing to BSE.
Sep 30, 2016 at 13:12 | Source: Moneycontrol.com
Cipla shares fell 6.5 percent intraday Friday after the company said the US health regulator issued four observations across three facilities in Goa.